Cedar Brook Financial Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-1,517
Closed -$257K – 434
2024
Q1
$257K Sell
1,517
-59
-4% -$11.1K 0.05% 350
2023
Q4
$310K Sell
1,576
-271
-15% -$48K 0.07% 283
2023
Q3
$321K Sell
1,847
-138
-7% -$25.1K 0.08% 238
2023
Q2
$342K Buy
+1,985
New +$343K 0.08% 254
2022
Q2
– Sell
-1,119
Closed -$211K – 397
2022
Q1
$211K Buy
1,119
+94
+9% +$18.6K 0.05% 352
2021
Q4
$250K Buy
+1,025
New +$225K 0.06% 318

Other funds holding ZTS

Cedar Brook Financial Partners's ZTS Position: Q2 2024 in Review

Cedar Brook Financial Partners sold out of Zoetis (ZTS) in Q2 2024, closing a stake of 1,517 shares — an estimated $257K sold.

Cedar Brook Financial Partners first reported a position in ZTS in Q4 2021 and held it in 6 quarters. The position peaked at $342K in Q2 2023. 1,739 funds tracked by Wall St. Rank hold ZTS as of Q2 2024.

  • Cedar Brook Financial Partners reported no remaining Zoetis position as of Q2 2024 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 1,517 Zoetis shares in Q2 2024, an estimated $257K.
  • Cedar Brook Financial Partners first reported a position in Zoetis in Q4 2021 and held it in 6 quarters.
  • Cedar Brook Financial Partners's Zoetis position peaked at $342K in Q2 2023.
  • 1,739 funds tracked by Wall St. Rank held Zoetis as of Q2 2024.

Based on Cedar Brook Financial Partners's 13F filing for Q2 2024, filed 15 Jul 2024.